Tranexamic acid for preventing postpartum blood loss after cesarean delivery: A systematic review and meta-analysis of randomized controlled trials

Acta Obstetricia et Gynecologica Scandinavica

Volumn 95, Issue 1, 2016, Pages 28-37

  Simonazzi, Giuliana ^a   Bisulli, Maria ^a   Saccone, Gabriele ^b   Moro, Elisa ^a   Marshall, Ariela ^c,d   Berghella, Vincenzo ^e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

cesarean delivery; postpartum hemorrhage; Tranexamic acid

Indexed keywords

HEMOGLOBIN; OXYTOCIN; PLACEBO; TRANEXAMIC ACID; UTEROTONIC AGENT; ANTIFIBRINOLYTIC AGENT; OXYTOCIC AGENT;

BLOOD TRANSFUSION; CESAREAN SECTION; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; EPIDURAL ANESTHESIA; HUMAN; META ANALYSIS; MORBIDITY; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPINAL ANESTHESIA; SYSTEMATIC REVIEW; THROMBOEMBOLISM; BLOOD; FEMALE; METABOLISM; POSTOPERATIVE HEMORRHAGE; PREGNANCY; STATISTICS AND NUMERICAL DATA;

ANTIFIBRINOLYTIC AGENTS; BLOOD TRANSFUSION; FEMALE; HEMOGLOBINS; HUMANS; OXYTOCICS; POSTOPERATIVE HEMORRHAGE; POSTPARTUM HEMORRHAGE; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANEXAMIC ACID;

EID: 84954197650     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12798     Document Type: Review

References (26)

1. World Health Organization (WHO). WHO guidelines for the management of postpartum haemorrhage and retained placenta. Available online at: http://whqlibdoc.who.int/publications/2009/9789241598514-eng.pdf (accessed 3 November 2014).
2. Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009;9:55.
3. Bonnar J. Massive obstetric haemorrhage. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14:1-18.
4. Kambo I, Bedi N, Dhillon BS, Saxena NC. A critical appraisal of cesarean section rates at teaching hospitals in India. Int J Gynaecol Obstet. 2002;79:151-8.
5. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibronolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2007;4:CD001886.
6. Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg. 2013;100:1271-9.
7. Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, et al. The CRASH-2 trial: a randomized controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patient. Health Technol Assess. 2013;17:1-79.
8. Bidolegui F, Arce G, Lugones A, Pereira S, Vindver G. Tranexmiac acid reduces blood loss and transfusion in patients undergoing total knee arthroplasy without tourniquet: a prospective randomized controlled trial. Open Orthop J. 2014;8:250-4.
9. Gai MY, Wu LF, Su QF, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multicenter randomized trial. Eur J Obstet Gynecol Reprod Biol. 2004;112:154-7.
10. Gungorduk K, Yildirim G, Asicioglu O, Gungorduk OC, Sudolmus S, Ark C. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. Am J Perinatol. 2011;28:233-40.
11. Movafegh A, Eslamian L, Dorabadi A. Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery. Int J Gynaecol Obstet. 2011;115:224-6.
12. Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gulmezoglu AM. Effectiveness of Tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. J Matern Fetal Neonatal Med. 2013;26:1705-9.
13. Xu J, Gao W, Ju Y. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double blind randomization trial. Arch Gynecol Obstet. 2013;287:463-8.
14. Shahid A, Khan A. Tranexamic acid in decreasing blood loss during and after caesarean section. J Coll Physicians Surg Pak. 2013;23:459-62.
15. Senturk MB, Cakmak Y, Yildiz G, Yildiz P. Tranexamic acid for cesarean section: a double blind, placebo controlled, randomized clinical trial. Arch Gynecol Obstet. 2013;287:641-5.
16. Ahmed MR, Sayed Ahmed WA, Madny EH, Arafa AM, Said MM. Efficacy of tranexamic acid in decreasing blood loss in elective caesarean delivery. J Matern Fetal Neonatal Med. 2015;28:1014-8.
17. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006-12.
18. Higgins JPT, Altman DG, Sterne JAC. Cochrane handbook for systematic reviews of interventions, version 5.1.0 (update March 2011). The Cochrane Collaboration, 2011. Available online at: www.cochrane-handbook.org (accessed 5 November 2014).
19. Goswami U, Sarangi S, Gupta S, Babbar S. Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: a double-blind randomized case control prospective trial. Saudi J Anaesth. 2013;7:427-31.
20. Novikova N, Hofmeyr GJ, Cluver C. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2015;6:CD007872.
21. Faraoni D, Carlier C, Samama CM, Levy JH, Ducloy-Bouthors AS. Efficacy and safety of tranexamic acid administration for the prevention and/or the treatment of post-partum haemorrhage: a systematic review with meta-analysis. Ann Fr Anesth Reanim. 2014;33:563-71.
22. Heesen M, Bohmer J, Klohr S, Rossaint R, van de Velde M, Dudenhausen JW, et al. Prophylactic tranexamic acid in parturients at low risk for post-partum haemorrhage: systematic review and meta-analysis. Acta Anaesthesiol Scand. 2014;58:1075-85.
23. Pilbrant A, Schannong M, Vessman J. Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol. 1981;20:65-72.
24. Perel P, Ker K, Morales Uribe CH, Roberts I. Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database Syst Rev. 2013;1:CD010245.
25. Yeguiayan JM, Rosencher N, Vivien B. Early administration of tranexamic acid in trauma patients. Lancet. 2011;378:27-8.
26. Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014;349:g4829.